Advanced

DAI-10 is as good as DAI-30 in schizophrenia

Nielsen, Rene Ernst; Lindstrom, Eva; Nielsen, Jimmi and Levander, Sten LU (2012) In European Neuropsychopharmacology 22(10). p.747-750
Abstract
Drug attitude inventory (DAI-30) is considered to be the best predictor of poor adherence in first-episode schizophrenia. We compared the short version (DAM 0) with DAI-30 in long-term schizophrenia, documented if DAI was associated with poor insight, PANSS and GAF and constructed DAI-10 percentiles. DAI-30 and DAI-10 were homogenous (r = 0.82 and 0.72, respectively) with good test-retest reliability (0.79). The correlation between the DAI versions was high (0.94). Percentile scores of DAI-10 were computed. DAI is an easy-to-use self-report instrument seemingly assessing a unique clinical dimension relevant to non-adherence. DAI-10 might be preferred for its simplicity and good psychometric properties. (C) 2012 Elsevier B.V. and ECNP. All... (More)
Drug attitude inventory (DAI-30) is considered to be the best predictor of poor adherence in first-episode schizophrenia. We compared the short version (DAM 0) with DAI-30 in long-term schizophrenia, documented if DAI was associated with poor insight, PANSS and GAF and constructed DAI-10 percentiles. DAI-30 and DAI-10 were homogenous (r = 0.82 and 0.72, respectively) with good test-retest reliability (0.79). The correlation between the DAI versions was high (0.94). Percentile scores of DAI-10 were computed. DAI is an easy-to-use self-report instrument seemingly assessing a unique clinical dimension relevant to non-adherence. DAI-10 might be preferred for its simplicity and good psychometric properties. (C) 2012 Elsevier B.V. and ECNP. All rights reserved. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Rating scales, Schizophrenia, Cognitive neuroscience, Insight, DAI
in
European Neuropsychopharmacology
volume
22
issue
10
pages
747 - 750
publisher
Elsevier
external identifiers
  • wos:000309781200007
  • scopus:84865565648
ISSN
1873-7862
DOI
10.1016/j.euroneuro.2012.02.008
language
English
LU publication?
yes
id
e20948fa-1efc-4fb8-b173-0e51feb12eec (old id 3174973)
date added to LUP
2012-12-03 06:53:54
date last changed
2017-10-29 03:02:42
@article{e20948fa-1efc-4fb8-b173-0e51feb12eec,
  abstract     = {Drug attitude inventory (DAI-30) is considered to be the best predictor of poor adherence in first-episode schizophrenia. We compared the short version (DAM 0) with DAI-30 in long-term schizophrenia, documented if DAI was associated with poor insight, PANSS and GAF and constructed DAI-10 percentiles. DAI-30 and DAI-10 were homogenous (r = 0.82 and 0.72, respectively) with good test-retest reliability (0.79). The correlation between the DAI versions was high (0.94). Percentile scores of DAI-10 were computed. DAI is an easy-to-use self-report instrument seemingly assessing a unique clinical dimension relevant to non-adherence. DAI-10 might be preferred for its simplicity and good psychometric properties. (C) 2012 Elsevier B.V. and ECNP. All rights reserved.},
  author       = {Nielsen, Rene Ernst and Lindstrom, Eva and Nielsen, Jimmi and Levander, Sten},
  issn         = {1873-7862},
  keyword      = {Rating scales,Schizophrenia,Cognitive neuroscience,Insight,DAI},
  language     = {eng},
  number       = {10},
  pages        = {747--750},
  publisher    = {Elsevier},
  series       = {European Neuropsychopharmacology},
  title        = {DAI-10 is as good as DAI-30 in schizophrenia},
  url          = {http://dx.doi.org/10.1016/j.euroneuro.2012.02.008},
  volume       = {22},
  year         = {2012},
}